Cargando…
A comprehensive overview of pneumococcal vaccination recommendations for adults in South Africa, 2022
Pneumococcal infections remain a common global cause of significant morbidity and mortality. The first recommendations for adult pneumococcal vaccination, published in South Africa in 1999, contained information only on the 23-valent polysaccharide vaccine (PPV23). With the introduction of the 13-va...
Autores principales: | Feldman, Charles, Dlamini, Sipho, Richards, Guy A., Black, John, Butler, India L. C., Cutland, Clare, Hefer, Eric, Hodkinson, Bridget, Kok, Adri, Manga, Pravin, Meiring, Susan, Molaudzi, Muhangwi, Moosa, Mahomed-Yunus S., Parker, Salim, Peter, Jonny, van Vuuren, Cloete, Verburgh, Estelle, Watermeyer, Gill |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641319/ https://www.ncbi.nlm.nih.gov/pubmed/36389298 http://dx.doi.org/10.21037/jtd-22-287 |
Ejemplares similares
-
Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update
por: Nel, Jeremy, et al.
Publicado: (2020) -
The cost-effectiveness of using pneumococcal conjugate vaccine (PCV13) versus pneumococcal polysaccharide vaccine (PPSV23), in South African adults
por: Feldman, Charles, et al.
Publicado: (2020) -
Adult antiretroviral therapy guidelines 2017
por: Meintjes, Graeme, et al.
Publicado: (2017) -
Appropriate clinical use of darunavir 800 mg
por: Moorhouse, Michelle A., et al.
Publicado: (2018) -
Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
por: Moorhouse, Michelle A., et al.
Publicado: (2018)